Abstract
Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the case of a diabetic patient of unstable angina with left bundle branch block who was prescribed ticagrelor post angioplasty. Electrocardiogram (ECG) revealed a complete heart block after about 1 week. Ticagrelor was stopped and replaced by clopidogrel. The patient became asymptomatic and ECG showed baseline rhythm after 1 week of stoppage of ticagrelor.
Original language | English |
---|---|
Pages (from-to) | 75-77 |
Number of pages | 3 |
Journal | Journal of Pharmacology and Pharmacotherapeutics |
Volume | 11 |
Issue number | 2 |
DOIs | |
Publication status | Published - 01-04-2020 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)